Skip to the page

Data / Form D filings / Phylos Bioscience, Inc.

Phylos Bioscience, Inc.: Form D filings

Phylos Bioscience, Inc., a company in Portland, OR, filed 21 Form D notices with the SEC between 2015 and 2025. The latest, on December 19, 2025, reports $583,418 sold of an offering with no set size to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2544 N.W. Nicolai Street, Suite B-06, Portland, OR, 97210
Phone
(503) 206-6599
Industry
Other
Entity type
Corporation
Incorporated in
Oregon
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1630986

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 19, 2025New noticeIndefinite$583,4188Dec 9, 2025sec.gov
Jan 23, 2025AmendmentIndefinite$4,518,51925Jan 29, 2020sec.gov
Nov 1, 2024New notice$4,000,000$1,805,037$2,194,9638Oct 15, 2024sec.gov
Jan 24, 2024AmendmentIndefinite$4,518,51925Jan 29, 2020sec.gov
Nov 7, 2023New noticeIndefinite$150,0001Nov 1, 2023sec.gov
Feb 17, 2023New notice$1,000,000$250,000$750,0001Feb 10, 2023sec.gov
Jan 26, 2023AmendmentIndefinite$4,518,51925Jan 29, 2020sec.gov
Jan 24, 2022AmendmentIndefinite$00Jan 29, 2020sec.gov
Dec 10, 2021New noticeIndefinite$00Yet to occursec.gov
May 5, 2021New notice$5,000,000$2,500,000$2,500,0004Apr 29, 2021sec.gov
Apr 19, 2021Amendment$26,000,000$12,158,792$13,841,20833Apr 8, 2019sec.gov
Jan 27, 2021Amendment$25,000,000$4,518,519$20,481,48133Mar 27, 2020sec.gov
May 5, 2020Amendment$26,000,000$12,158,792$13,841,20833Apr 8, 2019sec.gov
Jan 30, 2020New notice$25,000,000$0$25,000,0000Yet to occursec.gov
May 10, 2019Amendment$26,000,000$2,000,000$24,000,0002Apr 8, 2019sec.gov
Jan 3, 2019New notice$20,000,000$0$20,000,0000Yet to occursec.gov
Dec 26, 2017New notice$10,000,000$250,000$9,750,0001Dec 12, 2017sec.gov
Sep 16, 2016Amendment$5,500,000$1,430,000$4,070,0007Aug 31, 2015sec.gov
Sep 18, 2015Amendment$3,000,000$250,000$2,750,0001Aug 31, 2015sec.gov
Sep 17, 2015New notice$1,000,000$250,000$750,0001Aug 31, 2015sec.gov
Feb 3, 2015New notice$2,000,000$250,000$1,750,0001Jan 20, 2015sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Nishan KarassikExecutive Officer, Director
Barbara J PeacheyExecutive Officer
Ralph J RischExecutive Officer, Director
Timothy J GregoryDirector
David J PattersonDirector
Mina J MishrikeyDirector

Other companies in Oregon that filed recently

Every Form D from the week of Dec 15, 2025 · All recent filings in Oregon · All recent Other filings

Read from SEC EDGAR. Amount sold is what Phylos Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.